Literature DB >> 29494569

Notes from the Field: HIV Infection Investigation in a Rural Area - West Virginia, 2017.

Mary E Evans, Sarah M Labuda, Vicki Hogan, Christine Agnew-Brune, John Armstrong, Amarnath Babu Periasamy Karuppiah, Deborah Blankinship, Kate Buchacz, Kenya Burton, Sharon Cibrik, William Hoffman, Nathan Kirk, Chang Lee, Dondeena McGraw, M Cheryl Bañez Ocfemia, Nivedha Panneer, Pamela Reynolds, Bridget Rose, Melinda Salmon, Melissa Scott, Antoine Thompson, David Wills, Sherri A Young, Rahul Gupta, Loretta Haddy, Paul J Weidle, Miguella Mark-Carew.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29494569      PMCID: PMC5861700          DOI: 10.15585/mmwr.mm6708a6

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
From January to July 2017, the West Virginia Department of Health and Human Resources (WV DHHR) identified 10 cases of human immunodeficiency virus (HIV) infection in three counties where HIV diagnoses typically range from six to 13 annually (). In these counties, the spread of bloodborne pathogens via injection drug use (IDU) is a major public health concern, and risk reduction programs offering syringe services were not available, although they were available in other counties (,). As of July 2017, nine of the 10 persons identified were men who have sex with men (MSM), two of whom had reported a prior history of IDU. Coinfections with syphilis (five patients), hepatitis B virus (three), and hepatitis C virus (HCV) (two) were also documented. By September 2017, the sexual or injection contacts named by persons in the investigation expanded the original assessment area to encompass 15 counties, 14 of which were among the nation’s top 220 counties thought to be particularly vulnerable to rapid spread of HIV and HCV infections via IDU (). The investigated counties share some characteristics with rural Scott County, Indiana, where an HIV outbreak was linked to IDU in 2015 (), including a high prevalence of drug overdose deaths, prescription opioid sales, and unemployment. WV DHHR and CDC reviewed HIV surveillance and partner services data to identify persons with HIV infection diagnosed in 2017 who resided in one of the 15 counties at the time of diagnosis. These included HIV-infected persons who were epidemiologically linked (sex or IDU partner) or molecularly linked (by closely related HIV nucleotide sequences at a distance of ≤0.005 substitutions per site) to at least one case diagnosed in 2017 who resided in one of the 15 counties at the time of diagnosis. In addition, information on available health care services was obtained through individual interviews with 18 local providers and five persons from the investigation who had HIV infection. As of October 26, 2017, the investigation had identified 57 persons with diagnosed HIV infection, including 40 cases (73%) diagnosed in 2017 (Figure) and 17 cases diagnosed before 2017 that were epidemiologically linked (11 cases) or molecularly linked (six). Males accounted for 51 (89%) persons with HIV infection; 43 (75%) were white, and 28 (49%) were aged <30 years. The mode of transmission was male-to-male sexual contact in 34 cases (60%), IDU in five (9%), both male-to-male sexual contact and IDU in three (5%), heterosexual contact in two (4%), and unknown in 13 (23%). Ten (18%) persons had HIV Stage 3 (acquired immunodeficiency syndrome [AIDS]) at the time of diagnosis. All 40 persons with HIV infection diagnosed in 2017 had been linked to HIV care; 13 (77%) of the 17 persons diagnosed before 2017 had an HIV medical care visit in the past 6 months.
FIGURE

Number of HIV diagnoses per month and cumulative number of diagnoses per year — 15 West Virginia counties, 2015–2017

Abbreviation: HIV = human immunodeficiency virus.

Number of HIV diagnoses per month and cumulative number of diagnoses per year — 15 West Virginia counties, 2015–2017 Abbreviation: HIV = human immunodeficiency virus. Risk reduction programs that provide syringe services are available in three of the 15 counties (none of the original three counties in the investigation). HIV testing is available at all 15 county health department clinics. HIV medical care providers are available in three counties (including one of the original counties in the investigation). Ryan White HIV/AIDS Program case management services, which support organizations to deliver HIV care and treatment for low-income persons living with HIV infection, are available throughout the state. Providers who offer preexposure prophylaxis for prevention of HIV infection are available in clinic settings in four counties (including two of the original counties in the investigation). Local providers and persons with HIV infection who were interviewed described stigma, transportation from remote areas, and poor health literacy as challenges to HIV testing in rural areas. WV DHHR implemented strategies to limit further transmission of HIV among the MSM population and among persons who inject drugs. WV DHHR is expanding access to HIV testing and plans to work with county health departments to implement additional preexposure prophylaxis clinics. For example, a geotargeted advertisement in the 15 counties on popular MSM-focused social media sites was purchased to encourage HIV testing. In addition, in November, WV DHHR selected 11 health care entities across West Virginia for funding, including entitites in five of the counties in this investigation, to support comprehensive community-level prevention programs that include syringe services programs where they are permitted and desired. Continued efforts are underway to further characterize the HIV transmission network and potential HIV transmission through IDU risk behavior among patients and their extended contact networks.
  4 in total

1.  County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Authors:  Michelle M Van Handel; Charles E Rose; Elaine J Hallisey; Jessica L Kolling; Jon E Zibbell; Brian Lewis; Michele K Bohm; Christopher M Jones; Barry E Flanagan; Azfar-E-Alam Siddiqi; Kashif Iqbal; Andrew L Dent; Jonathan H Mermin; Eugene McCray; John W Ward; John T Brooks
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

2.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

3.  Opioid Overdose Outbreak - West Virginia, August 2016.

Authors:  Joel Massey; Michael Kilkenny; Samantha Batdorf; Sarah K Sanders; Debra Ellison; John Halpin; R Matthew Gladden; Danae Bixler; Loretta Haddy; Rahul Gupta
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-22       Impact factor: 17.586

4.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

  4 in total
  32 in total

Review 1.  Understanding Stimulant Use and Use Disorders in a New Era.

Authors:  Daniel Ciccarone; Steve Shoptaw
Journal:  Med Clin North Am       Date:  2022-01       Impact factor: 5.456

2.  HCV communication within ego-centric networks of men and women who inject drugs.

Authors:  Marisa Felsher; Karin E Tobin; Mark Sulkowski; Carl Latkin; Oluwaseun Falade-Nwulia
Journal:  Drug Alcohol Depend       Date:  2021-10-29       Impact factor: 4.492

3.  Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic.

Authors:  Leah Harvey; Jessica L Taylor; Sabrina A Assoumou; Jessica Kehoe; Elissa M Schechter-Perkins; Edward Bernstein; Alexander Y Walley
Journal:  J Addict Med       Date:  2021 Nov-Dec 01       Impact factor: 3.702

4.  HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.

Authors:  Suzan M Walters; Alex H Kral; Kelsey A Simpson; Lynn Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2020-09-23       Impact factor: 2.164

Review 5.  The Geography of Opioid Use Disorder: A Data Triangulation Approach.

Authors:  Patrick Sean Sullivan; Heather M Bradley; Carlos Del Rio; Eli S Rosenberg
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

6.  Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.

Authors:  Shuntai Zhou; Sabrina Sizemore; Matt Moeser; Scott Zimmerman; Erika Samoff; Victoria Mobley; Simon Frost; Andy Cressman; Michael Clark; Tara Skelly; Hemant Kelkar; Umadevi Veluvolu; Corbin Jones; Joseph Eron; Myron Cohen; Julie A E Nelson; Ronald Swanstrom; Ann M Dennis
Journal:  J Infect Dis       Date:  2021-03-03       Impact factor: 5.226

7.  A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19.

Authors:  Jessica L Taylor; Glorimar Ruiz-Mercado; Heather Sperring; Angela R Bazzi
Journal:  J Subst Abuse Treat       Date:  2021-01-07

8.  Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico.

Authors:  Katherine Wagner; Yuna Zhong; Eyasu Teshale; Kirsten White; Erin L Winstanley; Jennifer Hettema; Karla Thornton; Birgitta Bisztray; Philip Fiuty; Kimberly Page
Journal:  Drug Alcohol Depend       Date:  2021-01-11       Impact factor: 4.492

9.  COVID-19 and People Who Use Drugs - A Commentary.

Authors:  Suzan M Walters; David W Seal; Thomas J Stopka; Megan E Murphy; Wiley D Jenkins
Journal:  Health Behav Policy Rev       Date:  2020-10

10.  Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission.

Authors:  Leanne Whiteside-Mansell; LaTunja Sockwell; Daniel Knight; Cynthia Crone
Journal:  AIDS Behav       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.